✦ LIBER ✦

Treatment of Proximal Deep-Vein Thrombosis with the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients with Acute Symptomatic Deep-Vein Thrombosis) Study

✍ Scribed by G. Agnelli; A. Gallus; S.Z. Goldhaber

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of the oral direct f

✍ ON BEHALF OF THE BOTTICELLI INVESTIGATORS; THE WRITING COMMITTEE; H. BULLER; D. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Dose-escalation study of rivaroxaban (BA

✍ Bengt I. Eriksson; Lars C. Borris; Ola E. Dahl; Sylvia Haas; Menno V. Huisman; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 302 KB

BAY 59-7939: an oral, direct Factor Xa i

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB